Dr Reddy Laboratories Ltd (RDY) Tuesday said it has launched Montelukast Sodium Tablets 10 mg and Montelukast Sodium Chewable Tablets of 4 mg and 5 mg in the US market on August 6, after the United States Food & Drug Administration approved its ANDA.
These are bioequivalent generic versions of Singulair tablets and chewable tablets. Dr. Reddy's said its Montelukast Sodium Tablets in 10 mg and Montelukast Sodium Chewable Tablets in 4 mg and 5 mg are available in bottle counts of 30 and 90.
The Singulair tablets and Chewable tablets brand had U.S. sales of around $3.6 billion and $1.14 billion, respectively, for the twelve months ending March 2012, according to IMS Health.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.